Skip to content

Drug interactions

Basiliximab + Fingolimod

Severity: Major

Basiliximab and Fingolimod: major interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Basiliximab blocks the IL-2 receptor on activated T cells and fingolimod reduces circulating lymphocytes. Combined use may deepen immunosuppression and raise the risk of serious infection.

What this interaction means in plain words

Basiliximab and Fingolimod can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for.

Basiliximab belongs to Miscellaneous; Fingolimod belongs to Central Nervous System.

Evidence level: Low

Why it happens

Additive immunosuppression through T-cell activation blockade and lymphocyte sequestration.

What to do

Avoid the combination unless the benefit clearly outweighs the risk. If it is used, monitor lymphocyte counts and for signs of infection.

What to ask your pharmacist

  • Does the benefit of taking both outweigh the risk in my case?
  • Do I need any blood test, ECG or other check while on both?
  • What early warning signs should I watch for, and what should I do if they appear?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Basiliximab and Fingolimod, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Basiliximab with Fingolimod?

MediHelp rates the interaction as major. Basiliximab and Fingolimod can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for. Basiliximab blocks the IL-2 receptor on activated T cells and fingolimod reduces circulating lymphocytes. Combined use may deepen immunosuppression and raise the risk of serious infection.

How serious is the interaction between Basiliximab and Fingolimod?

MediHelp rates it major, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Avoid the combination unless the benefit clearly outweighs the risk. If it is used, monitor lymphocyte counts and for signs of infection.

What other medicines interact with Fingolimod?

MediHelp also lists interactions of Fingolimod with, for example, Adenovirus types 4 and 7 live, Bcg vaccine live, Pimozide. The full list is on the Fingolimod page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in